Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?
Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript
International Markets and Thermo Fisher (TMO): A Deep Dive for Investors
Examine Thermo Fisher's (TMO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Thermo Fisher to Sell Microbiology Business to Astorg
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.
Thermo Fisher Scientific: Why A Slow Q1 Does Not Reflect The Growth Opportunities
Thermo Fisher Scientific experienced a sharp post-Q1 selloff despite beating sales and EPS expectations and raising full-year guidance. Inorganic growth from recent acquisitions, notably Clario, contributed materially to raised EPS guidance and overall revenue outlook. Short-term headwinds in government/academic spending and diagnostics are not expected to derail Thermo's long-term growth strategy, supported by reshoring and AI adoption.
Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript
Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript
Thermo Fisher falls after earnings top estimates, but growth concerns persist
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) were down more than 7.5% on Thursday after investors weighed a stronger-than-expected quarterly profit against muted underlying growth and a still-cautious outlook despite an upgraded full-year revenue forecast. The life sciences tools and services company reported adjusted earnings per share of $5.44 for the first quarter of fiscal 2026, beating analyst expectations of $5.25.
TMO Q1 Earnings & Revenues Top Estimates, Stock Down in Pre-Market
TMO beats Q1 EPS and revenue estimates with steady growth, yet shares slip 4% in pre-market after results and mixed segment performance.
Thermo Fisher (TMO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Top Estimates
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.44 per share, beating the Zacks Consensus Estimate of $5.2 per share. This compares to earnings of $5.15 per share a year ago.
Thermo Fisher posts quarterly results beat as lab products, biopharma services grow
Thermo Fisher Scientific on Thursday reported first-quarter profit and revenue above Wall Street estimates, as growth in its laboratory products and biopharma services business helped offset softness in analytical instruments and specialty diagnostics.
Caprock Group LLC Acquires 1,804 Shares of Thermo Fisher Scientific Inc. $TMO
Caprock Group LLC lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 21.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,304 shares of the medical research company's stock after acquiring an additional
